Close menu




July 2nd, 2020 | 07:56 CEST

Aston Martin, SolGold, TUI - where to put the money?

  • Investments
Photo credits: pixabay.com

In recent months, central banks and politicians around the world have taken hand in hand actions to preserve the economy and social peace, despite restrictions to curb the spread of the Corona Pandemic. The money supply has been increased and travel opportunities have been restricted. The planned holidays were cancelled and jobs were moved to the home. Luxury was almost impossible to think of and nothing remained as it once was. What options do investors now have to deal with this situation?

time to read: 2 minutes | Author: Mario Hose
ISIN: GB00B0WD0R35 , DE000TUAG000 , GB00BFXZC448

Table of contents:


    Majestic luxury cars

    Aston Martin Lagonda is a British luxury car group with two brands and can look back on more than 100 years of experience. During the Corona Crisis, the British company had to increase its equity capital by issuing new ordinary shares in order to use the additional funds to compensate for the slump in sales. The Canadian billionaire Lawrence Stroll is one of Aston Martin's major shareholders.

    The shares of the manufacturer of the legendary James Bond car lost significant value during the Corona period. Aston Martin now wants to survive the crisis through cost-cutting and restructuring. The management has high hopes for the introduction of a new off-road vehicle called "DBX". However, industry experts criticise that the company is jumping on the trend much too late. Porsche, Bentley and other competitors have been profiting from the lucrative SUVs for quite some time.

    A promising strategy

    SolGold is a successful exploration company focused on the discovery and definition of very large copper and gold deposits. The company has a first-mover advantage in Ecuador, in a very promising but little explored section of the Andean Copper Belt, which hosts several large copper and gold projects. The deposits probably host half of the world's copper resources.

    From an investor's perspective, for projects of the magnitude of SolGold, it is important to remember that the right team with sufficient experience is particularly important to be successful in implementing a strategy. With copper and gold, the company focuses on commodities that can serve a booming market. The electrification of modern society requires huge amounts of copper and as the money supply increases, more and more people are fleeing with their wealth into the oldest currency in the world. With gold production expected to reach its historic peak in 2020, these are good conditions for SolGold and its shareholders.

    A reliable travel partner even in bad times

    The TUI Group is one of the world leaders in the tourism industry. As a responsible company, TUI is not only affected by global travel restrictions during the Corona Pandemic, but has also brought back stranded tourists from all parts of the world or looked after them. A nightmare from a business perspective. Not only did the revenues collapse, but money had to be spent to cope with the situation.

    No company can survive permanently without turnover and with considerable costs. For this reason, TUI, which got into the situation through no fault of its own, has also received financial support from the German government. In the EU, more and more travel is now becoming possible and also on a national level, the travel business is booming due to a lack of alternatives. However, before TUI can return to its former strength, the worldwide travel restrictions must fall.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by Stefan Feulner on October 4th, 2022 | 11:59 CEST

    RWE, Pathfinder Ventures, United Internet - Panic as an opportunity

    • Camping
    • Investments

    Last week, the crash prophets crawled out of their caves and outdid themselves with forecasts reaching the Corona lows at around 8,000 points in the leading German DAX index. Without a doubt, the general conditions for a sustained stock rally are moderate with the escalation of the Ukraine situation and concerns about further interest rate hikes. Nevertheless, there are attractive entry opportunities at the current level, which could pay off in cash in the long term.

    Read

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read